Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
The pilot plant is focused on scaling up beverage production and will support applications
The drug will target specific genetic mutations prevalent in certain types of cancers
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
4 FDA clearances & 61 EU MDR CE tags achieved for AI in 18 months
1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
Subscribe To Our Newsletter & Stay Updated